Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Palestinians forced from West Bank refugee camps left in limbo as Israeli demolitions go on- Last Christmas, 3 million viewers watched a Chiefs love story — will Bills fans fall just as hard this year?
- Israel approves 19 new West Bank settlements in major annexation push
- South Korea launches Earth-observation satellite on homegrown Nuri rocket
- Eating Brie, Gouda, cheddar may lower dementia risk, new study says
- IDF kills four terrorists equipped with weapons, surveillance gear near Gaza's Yellow Line
- Top Music and Dance Celebration: Which One Gets You Going?
- 7 Popular Vacation destinations In China
- KJ Apa stars as Jimmy Stewart in new biopic: See his transformation
